Flow Cytometry Market Report, Segments, Industry Growth, Size, Share, Forecast 2024-2032

Written by Mark Smith  »  Updated on: May 08th, 2024

Flow Cytometry Market Report, Segments, Industry Growth, Size, Share, Forecast 2024-2032

According to the recent report by IMARC Group, titled “Flow Cytometry Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on flow cytometry market forecast. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global flow cytometry market size reached US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% during 2024-2032.

Flow cytometry is a powerful analytical technique used in biology, medicine, and research to analyze and quantify the physical and chemical characteristics of cells or particles in a fluid suspension. This technique involves passing a cell or particle suspension through a laser beam and detecting the scattered and fluorescent light emitted by each individual cell or particle. Flow cytometry enables the simultaneous analysis of multiple parameters, such as cell size, complexity, viability, and protein expression levels, providing valuable insights into cellular function, disease diagnosis, and treatment monitoring. It is widely used in immunology, hematology, oncology, and microbiology research, as well as clinical diagnostics.

Get a Sample Copy of this Report: https://www.imarcgroup.com/flow-cytometry-market/requestsample

Market Trends:

The global market is majorly driven by the increasing prevalence of chronic and infectious diseases worldwide. Flow cytometry is widely used in immunology, hematology, oncology, and microbiology to diagnose and monitor diseases, assess immune function, and characterize cellular populations. Secondly, technological advancements in flow cytometry instruments, including the development of high-throughput systems, multiparametric analysis capabilities, and automation features, are driving market growth. These advancements enhance workflow efficiency, data accuracy, and sample throughput, making flow cytometry more accessible and cost-effective for research and clinical laboratories. Moreover, the expanding applications of flow cytometry beyond traditional research and diagnostics, such as drug discovery, stem cell research, and environmental monitoring, are driving market expansion. Flow cytometry's ability to analyze complex cellular interactions, identify rare cell populations, and quantify biomarkers makes it a valuable tool in various fields. Additionally, increasing investments in healthcare infrastructure, research and development activities, and collaborations among academic institutions, pharmaceutical companies, and biotechnology firms are further driving innovation and adoption of flow cytometry technologies.

Explore Full Report with Table of Contents: https://www.imarcgroup.com/flow-cytometry-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Agilent Technologies Inc.
  • Apogee Flow Systems Ltd.
  • BD (Becton, Dickinson and Company)
  • Beckman Coulter Inc. (Danaher Corporation)
  • Bio-RAD Laboratories Inc.
  • Enzo Life Sciences Inc.
  • Luminex Corporation
  • Merck KGaA
  • Sony Biotechnology Inc.
  • Sysmex Partec GmbH
  • Thermo Fisher Scientific Inc.

Flow Cytometry Market Segmentation:

Our report has categorized the market based on region, product and service, technology, application and end-user.

Breakup by Product and Service:

  • Instruments
  • Reagents and Consumables
  • Accessories
  • Software
  • Services

Breakup by Technology:

  • Cell-Based Flow Cytometry
  • Bead-Based Flow Cytometry

Breakup by Application:

  • Oncology
  • Drug Discovery
  • Disease Diagnosis
  • Stem Cell Therapy
  • Organ Transplantation
  • Hematology
  • Others

Breakup by End-User:

  • Hospitals and Clinics
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

  • Market Performance (2018-2023)
  • Market Outlook (2024-2032)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163



0 Comments Add Your Comment


Post a Comment

To leave a comment, please Login or Register


Related Posts